» Authors » Jian-Guo Zhu

Jian-Guo Zhu

Explore the profile of Jian-Guo Zhu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 521
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang J, Qian Y, Wu Z, Li Y, Guan Y, Sun C, et al.
Transl Cancer Res . 2024 Aug; 13(7):3783-3797. PMID: 39145083
Background: Tyrosine kinase inhibitors (TKIs) have become the preferred drugs for the treatment of chronic phase (CP) chronic myeloid leukemia (CML). This study aims to compare the safety and efficacy...
2.
Wang T, Liu C, Zhang L, Zhu J
Asian J Surg . 2024 May; 47(8):3780-3781. PMID: 38782691
No abstract available.
3.
Xu Y, Meng X, Zhao W, Liu D, Zhu J, Yao R, et al.
Zhongguo Zhong Yao Za Zhi . 2023 Jun; 48(7):1927-1935. PMID: 37282969
This study aims to explore the neuroprotective mechanism of ginsenoside Re(GS-Re) on drosophila model of Parkinson's disease(PD) induced by rotenone(Rot). To be specific, Rot was used to induce PD in...
4.
Xu Y, Liu D, Ning T, Zhu J, Yao R, Meng X, et al.
Zhongguo Zhong Yao Za Zhi . 2023 Jun; 48(8):2184-2192. PMID: 37282906
To investigate the antidepressant mechanism of Shenling Kaixin Granules(SLKX) in treating chronic unpredictable mild stress(CUMS) model rats. Ninety male SD rats were randomly divided into control group, model group, Shugan...
5.
Wang W, Xu T, Zhang J, Wang Y, Wang Y, Zhang W, et al.
J Thorac Dis . 2023 May; 15(4):1935-1947. PMID: 37197536
Background: Anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) are mainly used in the treatment of ALK-positive advanced non-small cell lung cancer (NSCLC), but a comprehensive clinical evaluation of ALK-TKIs is lacking....
6.
Li Y, Zhu J, Li Q, Zhu X, Tian J
BMC Neurol . 2023 Feb; 23(1):81. PMID: 36814261
Background: Ectopic pituitary adenoma (EPA) is defined as a special type of pituitary adenoma that originates outside of the sellar region, is extra- or intra-cranially located, and without connection to...
7.
Song J, Xu Y, Liu W, Xiao C, Liu B, Carbonara U, et al.
Transl Androl Urol . 2023 Feb; 12(1):90-96. PMID: 36760872
Background: Laparoendoscopic single-site (LESS) surgery is performed to further narrow the incisions and reduce tissue injury. It has been more than10 years since the surgery was first described. However, there...
8.
Song L, Huang C, Pan S, Zhu J, Cheng Z, Yu X, et al.
Expert Rev Clin Pharmacol . 2022 Nov; 16(1):83-91. PMID: 36373407
Background: Cyclosporin A is a calcineurin inhibitor which has a narrow therapeutic window and high interindividual variability. Various population pharmacokinetic models have been reported; however, professional software and technical personnel...
9.
He W, Zhu J, Pylypenko D, Liu F, Wang M, Wu Y, et al.
Medicine (Baltimore) . 2022 Oct; 101(40):e30861. PMID: 36221390
To synthetically evaluate the diagnostic accuracy of image features for differentiating benign from malignant gallbladder wall thickening disease with non-contrast MRI and establish the optimal diagnostic indicator. A total of...
10.
Zhang J, Zhao R, Xia F, Li Y, Wang R, Guan X, et al.
Ann Palliat Med . 2022 Sep; 11(8):2709-2719. PMID: 36064361
Background: Chemotherapy-induced thrombocytopenia (CIT) is a common adverse reaction to chemotherapy that can lead to treatment delay, platelet transfusion, thereby increasing treatment costs, reducing chemotherapy effectiveness and affecting prognosis. Based...